Susquehanna International Group
APGN

Susquehanna International Group’s Apexigen, Inc. Common Stock APGN Stock Holding History

Susquehanna International Group’s Portfolio APGN Stock Details APGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,700
Closed -$8.76K – 13918
2022
Q4 		$8.76K Buy
+12,700
New +$24.8K ﹤0.01% 11954

Other funds holding APGN

DCMIC
Decheng Capital Management III (Cayman) Grand Cayman, Cayman Islands $300M AUM 15.74% 1-Year Est. Return
YF
Yu Fan $97M AUM 57.2% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Susquehanna International Group's APGN Position: Q2 2023 in Review

Susquehanna International Group sold out of Apexigen, Inc. Common Stock (APGN) in Q2 2023, closing a stake of 15,546 shares — an estimated $7.77K sold.

Susquehanna International Group first reported a position in APGN in Q3 2021 and held it in 5 quarters. The position peaked at $1.15M in Q2 2022. 17 funds tracked by Wall St. Rank hold APGN as of Q2 2023.

  • Susquehanna International Group reported no remaining Apexigen, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Susquehanna International Group sold 15,546 Apexigen, Inc. Common Stock shares in Q2 2023, an estimated $7.77K.
  • Susquehanna International Group first reported a position in Apexigen, Inc. Common Stock in Q3 2021 and held it in 5 quarters.
  • Susquehanna International Group's Apexigen, Inc. Common Stock position peaked at $1.15M in Q2 2022.
  • 17 funds tracked by Wall St. Rank held Apexigen, Inc. Common Stock as of Q2 2023.

Based on Susquehanna International Group's 13F filing for Q2 2023, filed 11 Aug 2023.